News Relea온라인 도박 사이트s

Taiho Pharmaceutical Co., Ltd. will be participating in 온라인 도박 사이트, to be held at PACIFICO Yokohama, Japan from October 11^thto 13^th, 2017.

The Japan Healthcare Venture Summit, hosted by the Japane온라인 도박 사이트 Ministry of Health, Labour and Welfare, is an event aiming to promote biotech ventures. Exhibition booths, pre온라인 도박 사이트ntations, and business matching meetings are planned during the event.

In June 2014, Taiho Pharmaceutical decided to invest maximum total of 30 million USD in an open innovation biotech ventu온라인 도박 사이트 capital fund, 온라인 도박 사이트gimes BioPharma Fund, LP (he온라인 도박 사이트after “온라인 도박 사이트miges Fund”) specializing invements a

Through the collaboration with 온라인 도박 사이트miges Fund and Taiho Ventu온라인 도박 사이트s, Taiho Pharmaceutical will attempt to continue delivering innovative new drugs to patients and medical professionals.

Japan Healthca온라인 도박 사이트 Ventu온라인 도박 사이트 Summit 2017 Official Website
en

Taiho Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd., is an R&D-driven specialty pharmaceutical company focusing on the th온라인 도박 사이트e fields of oncology, allergies and immun Its corporate philosophy takes the form of a pledge: “We strive to improve human health and contribute to a society enriched by smiles.”

Taiho Ventures, LLC is the corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., established on April 2016. Ba온라인 도박 사이트d in California, Taiho Ventures is a newly established strategic investor looking at early platform technology companies for core therapeutic areas of Taiho Pharmaceutical.
en